You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
醫思健康(02138.HK)擬1億港元收購香港多專科醫療服務供應商70%股權
格隆匯 11-08 07:16

格隆匯11月8日丨醫思健康(02138.HK)發佈公告,2021年11月5日,公司、買方(即公司的間接全資附屬公司)、賣方(Sky Pavilion Group Ltd.,由賣方擔保人全資擁有)與賣方擔保人訂立買賣協議,據此賣方有條件同意出售目標公司70%股權,總代價爲現金1億港元,惟須遵守買賣協議的條款及條件。

賣方及賣方擔保人均向買方及公司各自保證,目標集團的經審覈收入總額將不少於各相關期間的保證收入總額。其中,首個期間保證收入5.59億港元,第二個期間保證收入6.17億港元,收入保證期間(即自2022年1月1日起至2025年12月31日止期間)保證收入總計11.767億港元。

於該公告日期,目標集團(即Premier Medical Group (BVI) Limited及其不時的附屬公司)在香港經營5個醫療中心,並聘有超過30名全職註冊醫生。目標集團自2006年起在香港提供醫療服務,爲提供廣泛醫療服務的多專科醫療服務供應商。收購事項將有助集團進一步提升其作爲多專科醫療服務供應商的醫療及保健服務,併爲集團增添6項額外醫療專科,包括麻醉科、內分泌、糖尿病及代謝、血液及血液腫瘤科、兒童呼吸系統科、生殖醫學專科及呼吸系統科。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account